NM_006231.4:c.6233G>A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 0P and 2B. BP4_Moderate
The NM_006231.4(POLE):c.6233G>A(p.Arg2078Gln) variant causes a missense change. The variant allele was found at a frequency of 0.0000513 in 1,461,570 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_006231.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
POLE | NM_006231.4 | c.6233G>A | p.Arg2078Gln | missense_variant | Exon 45 of 49 | ENST00000320574.10 | NP_006222.2 | |
POLE | XM_011534795.4 | c.6233G>A | p.Arg2078Gln | missense_variant | Exon 45 of 48 | XP_011533097.1 | ||
POLE | XM_011534797.4 | c.5312G>A | p.Arg1771Gln | missense_variant | Exon 37 of 40 | XP_011533099.1 | ||
POLE | XM_011534802.4 | c.3221G>A | p.Arg1074Gln | missense_variant | Exon 21 of 24 | XP_011533104.1 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.0000159 AC: 4AN: 251474Hom.: 0 AF XY: 0.0000221 AC XY: 3AN XY: 135908
GnomAD4 exome AF: 0.0000513 AC: 75AN: 1461570Hom.: 0 Cov.: 32 AF XY: 0.0000591 AC XY: 43AN XY: 727134
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not provided Uncertain:2
This sequence change replaces arginine, which is basic and polar, with glutamine, which is neutral and polar, at codon 2078 of the POLE protein (p.Arg2078Gln). This variant is present in population databases (rs745721448, gnomAD 0.006%). This missense change has been observed in individual(s) with gastrointestinal cancer (PMID: 34326862). ClinVar contains an entry for this variant (Variation ID: 473787). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge -
Hereditary cancer-predisposing syndrome Uncertain:1
The p.R2078Q variant (also known as c.6233G>A), located in coding exon 45 of the POLE gene, results from a G to A substitution at nucleotide position 6233. The arginine at codon 2078 is replaced by glutamine, an amino acid with highly similar properties. This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Based on the available evidence, the clinical significance of this variant remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at